Cargando…
Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study
(1) Background: Thrombophilia testing utility has remained controversial since its clinical introduction, because data on its influence on treatment decisions are limited. (2) Methods: We conducted a single-center retrospective cohort study of 3550 unselected patients referred for thrombophilia cons...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316471/ https://www.ncbi.nlm.nih.gov/pubmed/35887951 http://dx.doi.org/10.3390/jcm11144188 |
_version_ | 1784754820820762624 |
---|---|
author | Vrotniakaite-Bajerciene, Kristina Tritschler, Tobias Jalowiec, Katarzyna Aleksandra Broughton, Helen Brodard, Justine Porret, Naomi Azur Haynes, Alan Rovo, Alicia Kremer Hovinga, Johanna Anna Aujesky, Drahomir Angelillo-Scherrer, Anne |
author_facet | Vrotniakaite-Bajerciene, Kristina Tritschler, Tobias Jalowiec, Katarzyna Aleksandra Broughton, Helen Brodard, Justine Porret, Naomi Azur Haynes, Alan Rovo, Alicia Kremer Hovinga, Johanna Anna Aujesky, Drahomir Angelillo-Scherrer, Anne |
author_sort | Vrotniakaite-Bajerciene, Kristina |
collection | PubMed |
description | (1) Background: Thrombophilia testing utility has remained controversial since its clinical introduction, because data on its influence on treatment decisions are limited. (2) Methods: We conducted a single-center retrospective cohort study of 3550 unselected patients referred for thrombophilia consultation at the Bern University Hospital in Switzerland from January 2010 to October 2020. We studied the influence of thrombophilia testing results on treatment decisions and evaluated the association between thrombophilia and thromboembolic and pregnancy-related morbidity events after testing up to 03/2021. (3) Results: In 1192/3550 patients (34%), at least one case of thrombophilia was found and 366 (10%) had high-risk thrombophilia. A total of 211/3550 (6%) work-ups (111/826 (13%) with low-risk thrombophilia and 100/366 (27%) with high-risk thrombophilia) led to an appropriate decision to extend or initiate anticoagulation, and 189 (5%) negative results led to the withholding of anticoagulation therapy inappropriately. A total of 2492 patients (69%) were followed up for >30 days, with a median follow-up of 49 months (range, 1–183 months). Patients with high-risk thrombophilia had a higher risk of subsequent venous thromboembolic events and pregnancy-related morbidity compared to those without thrombophilia. (4) Conclusions: Our study demonstrated the limited usefulness of thrombophilia work-up in clinical decision-making. High-risk thrombophilia was associated with subsequent venous thromboembolism and pregnancy-related morbidity. |
format | Online Article Text |
id | pubmed-9316471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93164712022-07-27 Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study Vrotniakaite-Bajerciene, Kristina Tritschler, Tobias Jalowiec, Katarzyna Aleksandra Broughton, Helen Brodard, Justine Porret, Naomi Azur Haynes, Alan Rovo, Alicia Kremer Hovinga, Johanna Anna Aujesky, Drahomir Angelillo-Scherrer, Anne J Clin Med Article (1) Background: Thrombophilia testing utility has remained controversial since its clinical introduction, because data on its influence on treatment decisions are limited. (2) Methods: We conducted a single-center retrospective cohort study of 3550 unselected patients referred for thrombophilia consultation at the Bern University Hospital in Switzerland from January 2010 to October 2020. We studied the influence of thrombophilia testing results on treatment decisions and evaluated the association between thrombophilia and thromboembolic and pregnancy-related morbidity events after testing up to 03/2021. (3) Results: In 1192/3550 patients (34%), at least one case of thrombophilia was found and 366 (10%) had high-risk thrombophilia. A total of 211/3550 (6%) work-ups (111/826 (13%) with low-risk thrombophilia and 100/366 (27%) with high-risk thrombophilia) led to an appropriate decision to extend or initiate anticoagulation, and 189 (5%) negative results led to the withholding of anticoagulation therapy inappropriately. A total of 2492 patients (69%) were followed up for >30 days, with a median follow-up of 49 months (range, 1–183 months). Patients with high-risk thrombophilia had a higher risk of subsequent venous thromboembolic events and pregnancy-related morbidity compared to those without thrombophilia. (4) Conclusions: Our study demonstrated the limited usefulness of thrombophilia work-up in clinical decision-making. High-risk thrombophilia was associated with subsequent venous thromboembolism and pregnancy-related morbidity. MDPI 2022-07-19 /pmc/articles/PMC9316471/ /pubmed/35887951 http://dx.doi.org/10.3390/jcm11144188 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vrotniakaite-Bajerciene, Kristina Tritschler, Tobias Jalowiec, Katarzyna Aleksandra Broughton, Helen Brodard, Justine Porret, Naomi Azur Haynes, Alan Rovo, Alicia Kremer Hovinga, Johanna Anna Aujesky, Drahomir Angelillo-Scherrer, Anne Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study |
title | Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study |
title_full | Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study |
title_fullStr | Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study |
title_full_unstemmed | Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study |
title_short | Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study |
title_sort | thrombophilia impact on treatment decisions, subsequent venous or arterial thrombosis and pregnancy-related morbidity: a retrospective single-center cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316471/ https://www.ncbi.nlm.nih.gov/pubmed/35887951 http://dx.doi.org/10.3390/jcm11144188 |
work_keys_str_mv | AT vrotniakaitebajercienekristina thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT tritschlertobias thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT jalowieckatarzynaaleksandra thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT broughtonhelen thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT brodardjustine thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT porretnaomiazur thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT haynesalan thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT rovoalicia thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT kremerhovingajohannaanna thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT aujeskydrahomir thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy AT angelilloscherreranne thrombophiliaimpactontreatmentdecisionssubsequentvenousorarterialthrombosisandpregnancyrelatedmorbidityaretrospectivesinglecentercohortstudy |